You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Glenmark Pharmaceuticals Ltd. operates through various business units such as Specialty Pharmaceuticals, Active Pharmaceutical Ingredients (API), and Generic Drugs. They also focus on innovative therapeutic segments including Dermatology, Oncology, and Respiratory products. |
Business Models for Each Product Line |
Glenmark generates revenue primarily through the development, manufacturing, and marketing of generic pharmaceuticals and active pharmaceutical ingredients. Specialty pharmaceuticals focus on branded formulations, where innovation and patents provide a competitive edge. Major expenses include R&D costs, manufacturing and production expenses, and sales and marketing costs. |
Future Opportunities for Growth |
Glenmark sees growth opportunities in expanding its specialty and innovative products, particularly in the novel biological targets and biosimilars. Emerging markets present an additional area for expansion. The company's focus on developing drugs in oncology and respiratory segments using its proprietary technology platforms is also seen as a potential growth driver. |
Potential Major Risks |
The company faces risks such as patent litigation, regulatory compliance issues, and drug pricing pressures. Currency fluctuations and geopolitical instability in key markets could also impact financial performance. Additionally, high R&D expenditure with uncertain outcomes poses a significant risk to its business strategy. |
Learn More about Glenmark Pharmaceuticals Ltd:
Company Insights by Algobear (ChatGPT);
Tell me more about Glenmark Pharmaceuticals Ltd's latest earnings (GLENMARK:Nse)
Who are some of Glenmark Pharmaceuticals Ltd's competitors? (GLENMARK:Nse)
Are analysts bullish on Glenmark Pharmaceuticals Ltd? Please show it in a table format. (GLENMARK:Nse)
Also read:
https://finance.yahoo.com/GLENMARK.NS/profile
Revenue | Quarterly Revenue Growth | Market Cap-Display | EBITDA-Display | Market Cap-Actual | EBITDA-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Forward P/E | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Revenue-Display | Revenue-Actual | EBITDA | Diluted EPS | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Operating Cash Flow-Display | Levered Free Cash Flow-Display | % Held by Insiders | % Held by Institutions |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13960.77 | 35.1% | 40823.19 Cr | 3068.74 Cr | 408231936000.0 | 30687387648.0 | 40823.19 | 40841.04 Cr | 408410390528.0 | 40841.04 | 34.05 | 2.92 | 2.42 | 2.92 | 13.31 | -1.26% | 14.1% | 13960.77 Cr | 139607703552.0 | 3068.74 | -7.1 | 1820.24 Cr | 18202439680.0 | 1820.24 | 1780.85 Cr | 17808490496.0 | 1780.85 | 0.2109 | nan Cr | nan Cr | 49.62% | 29.08% |
source:https://finance.yahoo.com/GLENMARK.NS/key-statistics
source:https://www.google.com/finance/quote/GLENMARK:NSE
Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|
Upside % (high) | 3.92% | -1.24% (1439) | 0.96% (1471.1) | 8.64% (1582.95) | 13.79% (1658) | 25.66% (1830.95) | 25.66% (1830.95) | 25.66% (1830.95) |
Downside % (low) | 10.96% | 5.98% (1370) | 6.98% (1355.4) | 12.46% (1275.5) | 12.46% (1275.5) | 31.37% (1000) | 76.08% (348.5) | 88.91% (161.65) |
Spread % | -7.04% | -7.22% | -6.02% | -3.83% | 1.32% | -5.71% | -50.43% | -63.25% |
GLENMARK's price used for computing the stats is 1457.1 as on date
Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
---|---|---|---|---|---|---|---|---|---|
Last Price-Trend PrevClose | 3.6% | 1.8% | 0.7% | 3.52% | 6.06% | -5.35% | 41.8% | 273.09% | 75.27% |
Last Price | 1457.1 | 1457.1 | 1457.1 | 1457.1 | 1457.1 | 1457.1 | 1457.1 | 1457.1 | 1457.1 |
Trend-Previous Close | 1406.4 | 1431.4 | 1447 | 1407.6 | 1373.8 | 1539.4 | 1027.6 | 390.55 | 831.35 |
GLENMARK's symbol cumulative return percent is computed basis data from date
5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5D window |
5D Opportunity:
SELL-ACTIVE
returns:
1.8%
(0.26%),
p.close: 1431.4
entry:
1435.05,
exit:
1411.71,
min.ret:
1.63%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
1.8%
(3.81%),
p.close: 1431.4
entry:
1485.94,
exit:
1483.81,
min.ret:
0.14%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
1.8%
(4.16%),
p.close: 1431.4
entry:
1491.0,
exit:
1486.75,
min.ret:
0.28%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.8%
(5.95%),
p.close: 1431.4
entry:
1516.55,
exit:
1524.34,
min.ret:
-0.51%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.8%
(5.44%),
p.close: 1431.4
entry:
1509.29,
exit:
1521.14,
min.ret:
-0.79%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.8%
(7.21%),
p.close: 1431.4
entry:
1534.56,
exit:
1542.75,
min.ret:
-0.53%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2W window |
2W Opportunity:
returns:
0.7%
(5.21%),
p.close: 1447
entry:
1522.41,
exit:
1514.22,
min.ret:
0.54%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
0.7%
(5.63%),
p.close: 1447
entry:
1528.54,
exit:
1518.64,
min.ret:
0.65%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
0.7%
(8.65%),
p.close: 1447
entry:
1572.09,
exit:
1586.84,
min.ret:
-0.94%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
0.7%
(7.97%),
p.close: 1447
entry:
1562.37,
exit:
1569.23,
min.ret:
-0.44%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
0.7%
(11.29%),
p.close: 1447
entry:
1610.39,
exit:
1617.98,
min.ret:
-0.47%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1M window |
1M Opportunity:
SELL-APPROACHING
returns:
3.52%
(7.06%),
p.close: 1407.6
entry:
1506.92,
exit:
1500.86,
min.ret:
0.4%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
3.52%
(14.29%),
p.close: 1407.6
entry:
1608.79,
exit:
1568.5,
min.ret:
2.5%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
3.52%
(11.71%),
p.close: 1407.6
entry:
1572.43,
exit:
1530.96,
min.ret:
2.64%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
3.52%
(18.13%),
p.close: 1407.6
entry:
1662.75,
exit:
1667.21,
min.ret:
-0.27%
Using: 1M trend, 0 Days Left
|
GLENMARK's symbol current price is 1457.1 (3.6%) as on . Yesterday's close was 1406.4. It's return velocities are computed basis data from date .